|
3Sbio Inc. (1530.HK) Avaliação DCF
CN | Healthcare | Biotechnology | HKSE
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
3SBio Inc. (1530.HK) Bundle
Procurando avaliar o valor intrínseco da 3Sbio Inc.? Nossa calculadora DCF (1530HK) integra dados do mundo real com extensas opções de personalização, permitindo refinar as previsões e aprimorar suas estratégias de investimento.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5,680.2 | 5,968.1 | 6,816.6 | 7,326.5 | 8,348.1 | 9,197.8 | 10,133.9 | 11,165.3 | 12,301.6 | 13,553.6 |
| Revenue Growth, % | 0 | 5.07 | 14.22 | 7.48 | 13.94 | 10.18 | 10.18 | 10.18 | 10.18 | 10.18 |
| EBITDA | 1,779.9 | 1,701.3 | 2,418.5 | 2,939.5 | 2,697.6 | 3,086.0 | 3,400.0 | 3,746.1 | 4,127.3 | 4,547.4 |
| EBITDA, % | 31.34 | 28.51 | 35.48 | 40.12 | 32.31 | 33.55 | 33.55 | 33.55 | 33.55 | 33.55 |
| Depreciation | 356.7 | 385.5 | 351.4 | 395.0 | 357.6 | 507.2 | 558.8 | 615.6 | 678.3 | 747.3 |
| Depreciation, % | 6.28 | 6.46 | 5.16 | 5.39 | 4.28 | 5.51 | 5.51 | 5.51 | 5.51 | 5.51 |
| EBIT | 1,423.2 | 1,315.7 | 2,067.1 | 2,544.6 | 2,339.9 | 2,578.8 | 2,841.3 | 3,130.4 | 3,449.0 | 3,800.1 |
| EBIT, % | 25.06 | 22.05 | 30.32 | 34.73 | 28.03 | 28.04 | 28.04 | 28.04 | 28.04 | 28.04 |
| Total Cash | 2,728.2 | 4,660.1 | 5,023.5 | 7,487.9 | 6,399.3 | 6,925.3 | 7,630.1 | 8,406.7 | 9,262.2 | 10,204.9 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1,616.4 | 1,049.9 | 1,472.6 | 1,399.3 | .0 | 1,595.8 | 1,758.2 | 1,937.2 | 2,134.3 | 2,351.6 |
| Account Receivables, % | 28.46 | 17.59 | 21.6 | 19.1 | 0 | 17.35 | 17.35 | 17.35 | 17.35 | 17.35 |
| Inventories | 564.5 | 661.7 | 737.5 | 760.7 | 830.5 | 959.8 | 1,057.5 | 1,165.1 | 1,283.7 | 1,414.3 |
| Inventories, % | 9.94 | 11.09 | 10.82 | 10.38 | 9.95 | 10.43 | 10.43 | 10.43 | 10.43 | 10.43 |
| Accounts Payable | 160.0 | 217.1 | 246.1 | 266.5 | 226.5 | 302.0 | 332.7 | 366.6 | 403.9 | 445.0 |
| Accounts Payable, % | 2.82 | 3.64 | 3.61 | 3.64 | 2.71 | 3.28 | 3.28 | 3.28 | 3.28 | 3.28 |
| Capital Expenditure | -519.4 | -1,048.3 | -1,223.8 | -1,040.0 | -752.3 | -1,248.5 | -1,375.5 | -1,515.5 | -1,669.8 | -1,839.7 |
| Capital Expenditure, % | -9.14 | -17.57 | -17.95 | -14.2 | -9.01 | -13.57 | -13.57 | -13.57 | -13.57 | -13.57 |
| Tax Rate, % | 21.69 | 21.69 | 21.69 | 21.69 | 21.69 | 21.69 | 21.69 | 21.69 | 21.69 | 21.69 |
| EBITAT | 1,133.1 | 1,123.1 | 1,826.5 | 2,143.6 | 1,832.3 | 2,145.0 | 2,363.3 | 2,603.8 | 2,868.8 | 3,160.8 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -1,050.4 | 986.7 | 484.5 | 1,569.2 | 2,727.1 | -246.0 | 1,317.1 | 1,451.2 | 1,598.9 | 1,761.6 |
| WACC, % | 6.47 | 6.53 | 6.56 | 6.52 | 6.46 | 6.51 | 6.51 | 6.51 | 6.51 | 6.51 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 4,659.4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 1,797 | |||||||||
| Terminal Value | 39,878 | |||||||||
| Present Terminal Value | 29,098 | |||||||||
| Enterprise Value | 33,758 | |||||||||
| Net Debt | 2,295 | |||||||||
| Equity Value | 31,462 | |||||||||
| Diluted Shares Outstanding, MM | 2,442 | |||||||||
| Equity Value Per Share | 12.89 |
What You'll Receive
- Customizable Excel Template: A tailored Excel-based DCF Calculator featuring pre-filled financial data for 3SBio Inc. (1530HK).
- Authentic Data: Access to historical figures and future projections (highlighted in the yellow cells).
- Flexible Forecasting: Adjust key assumptions such as revenue growth, EBITDA margin, and WACC as needed.
- Instant Calculations: Quickly visualize how your inputs influence 3SBio Inc.'s (1530HK) valuation.
- Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Layout: Organized for straightforward navigation, complete with step-by-step guidance.
Key Features
- Advanced DCF Calculator: Incorporates comprehensive unlevered and levered DCF valuation models tailored for 3SBio Inc. (1530HK).
- WACC Calculator: Features a pre-configured Weighted Average Cost of Capital sheet with adjustable inputs specific to 3SBio Inc. (1530HK).
- Editable Forecast Assumptions: Customize growth rates, capital expenditures, and discount rates relevant to 3SBio Inc. (1530HK).
- Built-In Financial Ratios: Evaluate profitability, leverage, and efficiency ratios for 3SBio Inc. (1530HK).
- Dashboard and Charts: Visual representations provide a clear summary of key valuation metrics for 3SBio Inc. (1530HK), facilitating easy analysis.
How It Operates
- Download: Obtain the pre-prepared Excel file containing 3SBio Inc.’s (1530HK) financial data.
- Customize: Modify forecasts such as revenue growth, EBITDA margin, and WACC to fit your analysis.
- Update Automatically: Watch as intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Generate various projections and evaluate results instantly.
- Make Decisions: Leverage the valuation findings to inform your investment approach.
Why Choose This Calculator for 3SBio Inc. (1530HK)?
- Designed for Experts: A sophisticated tool utilized by analysts, CFOs, and industry consultants.
- Accurate Data: Historical and projected financials for 3SBio Inc. pre-loaded for precision.
- Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Comprehensive Outputs: Automatically calculates intrinsic value, NPV, and other key performance indicators.
- User-Friendly: Detailed step-by-step instructions assist you throughout the entire process.
Who Can Benefit from 3SBio Inc. (1530HK)?
- Investors: Gain insights and make informed decisions with our advanced valuation tools.
- Financial Analysts: Streamline your workflow with our ready-to-use DCF model, designed for easy customization.
- Consultants: Effortlessly modify templates to enhance client presentations or reports.
- Finance Enthusiasts: Expand your knowledge of valuation methods through practical, real-world examples.
- Educators and Students: Utilize this resource as an effective learning aid in finance-related coursework.
What the Template Includes
- Preloaded 3SBio Data: Historical and forecasted financial metrics, encompassing revenue, EBIT, and capital expenditures.
- DCF and WACC Models: High-quality templates for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for modifying revenue growth, tax rates, and discount rates.
- Financial Statements: Detailed annual and quarterly financials for enhanced analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios for performance assessment.
- Dashboard and Charts: Visual summaries showcasing valuation results and underlying assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.